USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Analysis of the Clinical Next-generation Sequencing Sector, Global, 2024-2030
Continued Investment in AI is Driving Transformational Growth by Accelerating Information Solutions Development
08-Nov-2024
Global
Market Research
KAE6-01-00-00-00
HC_2024_1121
This Frost & Sullivan analysis examines the clinical next-generation sequencing (NGS) industry, covering the different type of products, workflows, and applications for clinical purposes. The global market is projected to grow steadily from 2024 to 2030, achieving significant revenue milestones, driven largely by services and informatics segments. The NGS market encompasses end-to-end workflows, including library preparation, sequencing, and data analysis and interpretation, specifically designed for clinical applications across key end-user segments: pharmaceutical and biotechnology, and diagnostics. Within these sectors, NGS technologies are primarily employed to diagnose and monitor diseases, as well as for companion diagnostics, clinical trials, and patient stratification.
This analysis assesses the factors driving and restraining the growth of the use of NGS technology in clinical settings and offers case studies from North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East, Africa, and South Asia (MEASA). It also identifies the core growth opportunities that the industry presents by evaluating industry segments, the regulatory environment, and emerging business models, as well as market revenue and forecasts.
Scope of Analysis
Segmentation
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Clinical Next-generation Sequencing Industry
Competitive Environment
Key Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Considerations
Revenue Forecast
Revenue Forecast by Product
Revenue Forecast by Workflow
Revenue Forecast by Application
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis (continued)
Pricing Trends and Forecast Analysis
Revenue Share
Revenue Share Analysis
Competitive Players
Competitive Players (continued)
Company Informatics Solutions for Applications
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis (continued)
Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine
Growth Opportunity 1: Integration of Multi-omics Data for Personalized Medicine (continued)
Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer
Growth Opportunity 2: Minimal Residual Disease Detection and Treatment in Cancer (continued)
Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research
Growth Opportunity 3: Expansion of Single-cell and Spatial Omics in Clinical Research (continued)
Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA
Growth Opportunity 4: Genomics Initiatives and Bioinformatics Development in APAC and MEASA (continued)
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Clinical NGS: Growth Metrics, Global, 2024
- Clinical NGS: Growth Drivers, Global, 2025-2030
- Clinical NGS: Growth Restraints, Global, 2025-2030
- Clinical NGS: Revenue Forecast, Global, 2024-2030
- Clinical NGS: Revenue Forecast by Product, Global, 2024-2030
- Clinical NGS: Revenue Forecast by Workflow, Global, 2024-2030
- Clinical NGS: Revenue Forecast by Application, Global, 2024-2030
- Clinical NGS: Revenue Forecast by Region, Global, 2024-2030
- Clinical NGS: Revenue Share of Top 4 Participants, Global, 2024
- Instruments: Growth Metrics, Global, 2024
- Instruments: Revenue Forecast, Global, 2024-2030
- Instruments: Revenue Forecast by Region, Global, 2024-2030
- Workflow Solutions: Growth Metrics, Global, 2024
- Workflow Solutions: Revenue Forecast, Global, 2024-2030
- Workflow Solutions: Revenue Forecast by Region, Global, 2024-2030
- Services: Growth Metrics, Global, 2024
- Services: Revenue Forecast, Global, 2024-2030
- Services: Revenue Forecast by Region, Global, 2024-2030
- Informatics: Growth Metrics, Global, 2024
- Informatics: Revenue Forecast, Global, 2024-2030
- Informatics: Revenue Forecast by Region, Global, 2024-2030
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interven...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.